Panorama Prenatal Test (NIPT)

What is the Panorama Test?

The Panorama test is a safe and accurate, non-invasive prenatal DNA screening test (NIPT) that checks your baby for chromosome conditions by analysing abnormalities in the DNA. The Panorama test screens for a wide range of abnormalities including Down’s Syndrome, Patau Syndrome and Edwards’ Syndrome. It is the only test on the market that tests for Triploidy and can also determine the gender of your baby. Results determine the mother’s risk of having a baby with one of these defects.

Do I Need The Panorama Test?

The Panorama test is ideal for mothers who are anxious about birth defects in their baby and would like to be reassured about the health of their pregnancy. The International Society for Prenatal Diagnosis (ISPD) states that the Panorama test is appropriate for all ages. The test could give mothers over 35, who have a higher risk of giving birth to a baby with Down Syndrome, peace of mind.

How Is The Test Performed?

The test can be taken as early as nine weeks for women carrying a single baby. Mothers having the test will be asked by their doctor or consultant to sign consent and data release forms. This will be followed by an ultrasound and then a simple blood test from the mother’s arm, where two vials of blood will be drawn. The procedure is simple and quick, with no risk to the baby, and can be done in a single appointment. Results can be with your doctor or consultant seven working days from your test date and will give probability based results.

Accuracy & Risk

The Panorama test provides no risk to baby. This, combined with a low rate of test failure, and high rate of accuracy makes it a popular choice. Panorama is the only non-invasive prenatal screening test that differentiates between maternal and fetal DNA – thanks to Natera’s algorithm – and as such has a very low false positive rate. In singleton pregnancies* the test detects 99.9% of foetuses with Down Syndrome (Trisomy 21), 96.4% of foetuses with Edwards’ Syndrome (Trisomy 18), 99.9% of foetuses with Patau Syndrome (Trisomy X), 99.9% of foetuses with Triploidy and is able to detect both microdeletions and the sex of baby. It is also the only test on the market that checks for Triploidy.

*Panorama cannot be used for the following pregnancies: multiple gestation; egg donor or surrogate; bone marrow transplant recipients.